Empyrean Capital Partners, LP

Position in VIR — Vir Biotechnology, Inc.

CIK 1317195 LOS ANGELES, CA

Position in VIR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,161,660

-$3,567,428 QoQ

Shares Held

114,000

-78.4% QoQ

Ownership

0.067%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#90

of 237 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Empyrean Capital Partners, LP holds $18,125,072 across 3 Biotechnology names. VIR ranks #3 (6.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	75,400	$14,120,912
2	INBX	Inhibrx Biosciences, Inc.	30,000	$2,842,500
3	VIR	Vir Biotechnology, Inc. This page	114,000	$1,161,660

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,161,660	114,000	-78.4%	Shares	Sole	2026-08-14
2026-03-31	$4,729,088	527,800	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.